$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by the Blend of Double-Standardized Extracts of Aronia melanocarpa (Michx.) Elliot and Sambucus nigra L. 원문보기

Pharmaceuticals, v.15 no.5, 2022년, pp.619 -   

Ochnik, Michał (Laboratory of Virology, Department of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland) ,  Franz, Dominika (michal.ochnik@hirszfeld.pl (M.O.)) ,  Sobczyński, Maciej (dominika.franz@hirszfeld.pl (D.F.)) ,  Naporowski, Piotr (beata.orzechowska@hirszfeld.pl (B.O.)) ,  Banach, Mariusz (Laboratory of Virology, Department of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland) ,  Orzechowska, Beata (michal.ochnik@hirszfeld.pl (M.O.)) ,  Sochocka, Marta (dominika.franz@hirszfeld.pl (D.F.))

Abstract AI-Helper 아이콘AI-Helper

Viral and bacterial diseases are among the greatest concerns of humankind since ancient times. Despite tremendous pharmacological progress, there is still a need to search for new drugs that could treat or support the healing processes. A rich source of bioactive compounds with antiviral potency inc...

주제어

참고문헌 (51)

  1. 1. Paules C. Subbarao K. Influenza Lancet 2017 390 697 708 10.1016/S0140-6736(17)30129-0 28302313 

  2. 2. Mostafa A. Abdelwhab E.M. Mettenleiter T.C. Pleschka S. Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview Viruses 2018 10 497 10.3390/v10090497 30217093 

  3. 3. Krammer F. Smith G.J.D. Fouchier R.A.M. Peiris M. Kedzierska K. Doherty P.C. Palese P. Shaw M.L. Treanor J. Webster R.G. Influenza Nat. Rev. Dis. Primers 2018 4 3 10.1038/s41572-018-0002-y 29955068 

  4. 4. World Health Organization Influenza Available online: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccines-quality/influenza (accessed on 31 August 2021) 

  5. 5. De Clercq E. Li G. Approved Antiviral Drugs over the Past 50 Years Clin. Microbiol. Rev. 2016 29 695 747 10.1128/CMR.00102-15 27281742 

  6. 6. Heo Y.-A. Baloxavir: First Global Approval Drugs 2018 78 693 697 10.1007/s40265-018-0899-1 29623652 

  7. 7. FDA Influenza (Flu) Antiviral Drugs and Related Information 2020 Available online: https://www.fda.gov/drugs/information-drug-class/influenza-flu-antiviral-drugs-and-related-information (accessed on 4 September 2021) 

  8. 8. European Medicines Agency Antiviral Medicines for Pandemic Influenza Available online: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/pandemic-influenza/antiviral-medicines-pandemic-influenza (accessed on 4 September 2021) 

  9. 9. Bai Y. Jones J. Wong S.-S. Zanin M. Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance Viruses 2021 13 624 10.3390/v13040624 33917376 

  10. 10. Cui J. Li F. Shi Z.-L. Origin and evolution of pathogenic coronaviruses Nat. Rev. Microbiol. 2019 17 181 192 10.1038/s41579-018-0118-9 30531947 

  11. 11. Chen B. Tian E.-K. He B. Tian L. Han R. Wang S. Xiang Q. Zhang S. El Arnaout T. Cheng W. Overview of lethal human coronaviruses Signal Transduct. Target. Ther. 2020 5 89 10.1038/s41392-020-0190-2 32533062 

  12. 12. FDA Know Your Treatment Options for COVID-19 2021 Available online: https://www.fda.gov/consumers/consumer-updates/know-your-treatment-options-covid-19 (accessed on 26 September 2021) 

  13. 13. Dimitrova E.K. European Medicines Agency Veklury 2020 Available online: https://www.ema.europa.eu/en/medicines/human/EPAR/veklury (accessed on 26 September 2021) 

  14. 14. Beigel J.H. Tomashek K.M. Dodd L.E. Mehta A.K. Zingman B.S. Kalil A.C. Hohmann E. Chu H.Y. Luetkemeyer A. Kline S. Remdesivir for the Treatment of COVID-19—Preliminary report N. Engl. J. Med. 2020 383 1813 1826 10.1056/NEJMoa2007764 32445440 

  15. 15. Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety Front. Pharmacol. 2014 4 177 10.3389/fphar.2013.00177 24454289 

  16. 16. Richman D.D. Antiviral drug resistance Antivir. Res. 2006 71 117 121 10.1016/j.antiviral.2006.03.004 16621040 

  17. 17. Shyr Z.A. Cheng Y.-S. Lo D.C. Zheng W. Drug combination therapy for emerging viral diseases Drug Discov. Today 2021 26 2367 2376 10.1016/j.drudis.2021.05.008 34023496 

  18. 18. Denaro M. Smeriglio A. Barreca D. De Francesco C. Occhiuto C. Milano G. Trombetta D. Antiviral activity of plants and their isolated bioactive compounds: An update Phytother. Res. 2020 34 742 768 10.1002/ptr.6575 31858645 

  19. 19. Porter R.S. Bode R.F. A Review of the Antiviral Properties of Black Elder ( Sambucus nigra L.) Products Phytother. Res. 2017 31 533 554 10.1002/ptr.5782 28198157 

  20. 20. Młynarczyk K. Walkowiak-Tomczak D. Łysiak G.P. Bioactive properties of Sambucus nigra L. as a functional ingredient for food and pharmaceutical industry J. Funct. Foods 2018 40 377 390 10.1016/j.jff.2017.11.025 32362939 

  21. 21. Kokotkiewicz A. Jaremicz Z. Luczkiewicz M. Aronia Plants: A Review of Traditional Use, Biological Activities, and Perspectives for Modern Medicine J. Med. Food 2010 13 255 269 10.1089/jmf.2009.0062 20170359 

  22. 22. Jurikova T. Mlcek J. Skrovankova S. Sumczynski D. Sochor J. Hlavacova I. Snopek L. Orsavová J. Fruits of Black Chokeberry Aronia melanocarpa in the Prevention of Chronic Diseases Molecules 2017 22 944 10.3390/molecules22060944 

  23. 23. Vlachojannis J.E. Cameron M. Chrubasik S. A systematic review on the sambuci fructus effect and efficacy profiles. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives Phytother. Res. 2010 24 1 8 10.1002/ptr.2729 19548290 

  24. 24. Zheng J. Chen F. Wu K. Wang J. Li F. Huang S. Lu J. Huang J. Liu H. Zhou R. Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients PLoS Negl. Trop. Dis. 2021 15 e0009997 10.1371/journal.pntd.0009997 34843492 

  25. 25. Knox Y.M. Hayashi K. Suzutani T. Ogasawara M. Yoshida I. Shiina R. Tsukui A. Terahara N. Azuma M. Activity of anthocyanins from fruit extract of Ribes nigrum L. against influenza A and B viruses Acta Virol. 2001 45 209 215 11885927 

  26. 26. Amoros M. Simõs C.M.O. Girre L. Sauvager F. Cormier M. Synergistic Effect of Flavones and Flavonols against Herpes Simplex Virus Type 1 in Cell Culture. Comparison with the Antiviral Activity of Propolis J. Nat. Prod. 1992 55 1732 1740 10.1021/np50090a003 1338212 

  27. 27. Musarra-Pizzo M. Pennisi R. Ben-Amor I. Smeriglio A. Mandalari G. Sciortino M.T. In Vitro Anti-HSV-1 Activity of Polyphenol-Rich Extracts and Pure Polyphenol Compounds Derived from Pistachios Kernels ( Pistacia vera L.) Plants 2020 9 267 10.3390/plants9020267 32085514 

  28. 28. Wallace L.E. Liu M. van Kuppeveld F.J. de Vries E. de Haan C.A. Respiratory mucus as a virus-host range determinant Trends Microbiol. 2021 29 983 992 10.1016/j.tim.2021.03.014 33875348 

  29. 29. Swaminathan K. Dyason J.C. Maggioni A. von Itzstein M. Downard K.M. Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry Anal. Bioanal. Chem. 2013 405 6563 6572 10.1007/s00216-013-7068-x 23748498 

  30. 30. Kannan S. Kolandaivel P. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus J. Biomol. Struct. Dyn. 2018 36 4255 4269 10.1080/07391102.2017.1413422 29199545 

  31. 31. Ra J.-E. Seo K.H. Ko J.Y. Lee M.-J. Kang H.J. Kim S.L. Chung I.-M. Seo W.D. Antioxidative Effect and Neuraminidase Inhibitory Activity of Polyphenols Isolated from a New Korean Red Waxy Sorghum ( Sorghum bicolor L. cv. Hwanggeumchalsusu) J. Life Sci. 2015 25 786 794 10.5352/JLS.2015.25.7.786 

  32. 32. Chojnacka K. Skrzypczak D. Izydorczyk G. Mikula K. Szopa D. Witek-Krowiak A. Antiviral Properties of Polyphenols from Plants Foods 2021 10 2277 10.3390/foods10102277 34681326 

  33. 33. Pour P.M. Fakhri S. Asgary S. Farzaei M.H. Echeverría J. The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases Front. Pharmacol. 2019 10 1207 10.3389/fphar.2019.01207 31787892 

  34. 34. Kim C.-H. Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents Front. Pharmacol. 2021 12 590509 10.3389/fphar.2021.590509 34122058 

  35. 35. Marín L. Miguélez E.M. Villar C.J. Lombó F. Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties BioMed. Res. Int. 2015 2015 905215 10.1155/2015/905215 25802870 

  36. 36. González-Barrio R. Borges G. Mullen W. Crozier A. Bioavailability of Anthocyanins and Ellagitannins Following Consumption of Raspberries by Healthy Humans and Subjects with an Ileostomy J. Agric. Food Chem. 2010 58 3933 3939 10.1021/jf100315d 20218618 

  37. 37. Cao G. Muccitelli H.U. Sanchez-Moreno C. Prior R.L. Anthocyanins are absorbed in glycated forms in elderly women: A pharmacokinetic study Am. J. Clin. Nutr. 2001 73 920 926 10.1093/ajcn/73.5.920 11333846 

  38. 38. Wu X. Cao G. Prior R.L. Absorption and Metabolism of Anthocyanins in Elderly Women after Consumption of Elderberry or Blueberry J. Nutr. 2002 132 1865 1871 10.1093/jn/132.7.1865 12097661 

  39. 39. Manach C. Williamson G. Morand C. Scalbert A. Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clin. Nutr. 2005 81 230S 242S 10.1093/ajcn/81.1.230S 15640486 

  40. 40. Roschek B. Jr. Fink R. McMichael M.D. Li D. Alberte R.S. Elderberry flavonoids bind to and prevent H1N1 infection in vitro Phytochemistry 2009 70 1255 1261 10.1016/j.phytochem.2009.06.003 19682714 

  41. 41. Zhou J. Yuan X. Li L. Zhang T. Wang B. Comparison of different methods for extraction of Cinnamomi ramulus: Yield, chemical composition and in vitro antiviral activities Nat. Prod. Res. 2017 31 2909 2913 10.1080/14786419.2017.1299724 28322072 

  42. 42. Krawitz C. Abu Mraheil M. Stein M. Imirzalioglu C. Domann E. Pleschka S. Hain T. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses BMC Complement. Altern. Med. 2011 11 16 10.1186/1472-6882-11-16 21352539 

  43. 43. Kinoshita E. Hayashi K. Katayama H. Hayashi T. Obata A. Anti-Influenza Virus Effects of Elderberry Juice and Its Fractions Biosci. Biotechnol. Biochem. 2012 76 1633 1638 10.1271/bbb.120112 22972323 

  44. 44. Park S. Kim J.I. Lee I. Lee S. Hwang M.-W. Bae J.-Y. Heo J. Kim D. Han S.-Z. Park M.-S. Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses Biochem. Biophys. Res. Commun. 2013 440 14 19 10.1016/j.bbrc.2013.08.090 24012672 

  45. 45. Ramakrishnan M.A. Determination of 50% endpoint titer using a simple formula World J. Virol. 2016 5 85 86 10.5501/wjv.v5.i2.85 27175354 

  46. 46. da Silva R.F.R. Barreira J.C.M. Heleno S.A. Barros L. Calhelha R.C. Ferreira I.C.F.R. Anthocyanin Profile of Elderberry Juice: A Natural-Based Bioactive Colouring Ingredient with Potential Food Application Molecules 2019 24 2359 10.3390/molecules24132359 

  47. 47. Lee J. Finn C.E. Anthocyanins and other polyphenolics in American elderberry ( Sambucus canadensis ) and European elderberry ( S. nigra ) cultivars J. Sci. Food Agric. 2007 87 2665 2675 10.1002/jsfa.3029 20836175 

  48. 48. Zielińska A. Siudem P. Paradowska K. Gralec M. Kaźmierski S. Wawer I. Aronia melanocarpa Fruits as a Rich Dietary Source of Chlorogenic Acids and Anthocyanins: 1H-NMR, HPLC-DAD, and Chemometric Studies Molecules 2020 25 3234 10.3390/molecules25143234 32679898 

  49. 49. Wu X. Gu L. Prior R.L. McKay S. Characterization of anthocyanins and proanthocyanidins in some cultivars of Ribes, Aronia, and Sambucus and their antioxidant capacity J. Agric. Food Chem. 2004 52 7846 7856 10.1021/jf0486850 15612766 

  50. 50. Lambert F. Jacomy H. Marceau G. Talbot P.J. Titration of Human Coronaviruses Using an Immunoperoxidase Assay JoVE J. Vis. Exp. 2008 14 e751 10.3791/751 19066576 

  51. 51. Sochocka M. Sobczyński M. Ochnik M. Zwolińska K. Leszek J. Hampering Herpesviruses HHV-1 and HHV-2 Infection by Extract of Ginkgo biloba (EGb) and Its Phytochemical Constituents Front. Microbiol. 2019 10 2367 10.3389/fmicb.2019.02367 31681227 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로